We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BUSULFAN ACCORD, BUSULFAN INTAS (Accord Healthcare Pty Ltd)
Product name
BUSULFAN ACCORD, BUSULFAN INTAS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
249 working days (255)
Active ingredients
busulfan
Registration type
New generic medicine
Indication
BUSULFAN ACCORD, BUSULFAN INTAS (solution for injection) are indicated for use in combination with cyclophosphamide, melphalan or fludarabine in conditioning prior to haematopoietic stem cell transplantation.